Literature DB >> 32081214

Strategies to Improve Selection of Patients Without Typical Left Bundle Branch Block for Cardiac Resynchronization Therapy.

Odette A E Salden1, Kevin Vernooy2, Antonius M W van Stipdonk3, Maarten J Cramer4, Frits W Prinzen3, Mathias Meine4.   

Abstract

Cardiac resynchronization therapy (CRT) is becoming increasingly controversial in patients without typical left bundle branch block (LBBB). Yet, several recent studies displayed that a distinct subpopulation of patients with non-LBBB does benefit from CRT. Patients with non-LBBB should, therefore, not as a group be withheld from a potentially very beneficial therapy. Unfortunately, current clinical practice lacks validated selection criteria that may identify possible CRT responders in the non-LBBB subgroup. Consequently, clinical decision making in these patients is often challenging. A few studies, strongly differing in design, have proposed additive selection criteria for improved response prediction in patients with non-LBBB. There is accumulating evidence that more sophisticated echocardiographic dyssynchrony markers, taking into account the underlying electrical substrate responsive to CRT, can aid in the selection of patients with a non-LBBB who may benefit more favorably from CRT. Furthermore, it is important that cardiologists are aware of the shortcomings of current electrocardiographic selection criteria for CRT. Whereas these criteria provide an evidence-based approach for selecting patients for CRT, they do not necessarily guarantee the most optimal strategy for patient selection. Parameters obtained with vectorcardiography, such as QRS area, show potential to overcome the shortcomings of conventional electrocardiographic selection criteria and may improve response prediction regardless of QRS morphology.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac resynchronization therapy; dyssynchrony; heart failure; non–left bundle branch block; patient selection

Mesh:

Year:  2020        PMID: 32081214     DOI: 10.1016/j.jacep.2019.11.018

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  5 in total

1.  Shortening of time-to-peak left ventricular pressure rise (Td) in cardiac resynchronization therapy.

Authors:  Hans Henrik Odland; Manuel Villegas-Martinez; Stian Ross; Torbjørn Holm; Richard Cornelussen; Espen W Remme; Erik Kongsgard
Journal:  ESC Heart Fail       Date:  2021-09-12

2.  Vectorcardiographic QRS area as a predictor of response to cardiac resynchronization therapy.

Authors:  Mohammed A Ghossein; Antonius Mw van Stipdonk; Frits W Prinzen; Kevin Vernooy
Journal:  J Geriatr Cardiol       Date:  2022-01-28       Impact factor: 3.327

3.  Comparison between conduction system pacing and cardiac resynchronization therapy in right bundle branch block patients.

Authors:  Marina Strocchi; Karli Gillette; Aurel Neic; Mark K Elliott; Nadeev Wijesuriya; Vishal Mehta; Edward J Vigmond; Gernot Plank; Christopher A Rinaldi; Steven A Niederer
Journal:  Front Physiol       Date:  2022-09-21       Impact factor: 4.755

4.  Non-invasive estimation of QLV from the standard 12-lead ECG in patients with left bundle branch block.

Authors:  Jacob Melgaard; Peter M van Dam; Anders Sommer; Patricia Fruelund; Jens Cosedis Nielsen; Sam Riahi; Claus Graff
Journal:  Front Physiol       Date:  2022-09-21       Impact factor: 4.755

5.  Screening for regenerative therapy responders in heart failure.

Authors:  Satsuki Yamada; Ryounghoon Jeon; Armin Garmany; Atta Behfar; Andre Terzic
Journal:  Biomark Med       Date:  2021-06-25       Impact factor: 2.851

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.